Bioscrip News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

05.03.20	BioScrip, Inc. -- Moody's announces completion of a periodic review of ratings of Option Care Health, Inc. (Moodys)
15.05.19	BioScrip, Inc. -- Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable (Moodys)
15.05.19	BioScrip, Inc. -- Moody's upgrades BioScrip, Inc.'s Corporate Family Rating to B3, outlook stable (Moodys)
18.04.19	BioScrip, Inc. -- Moody's announces completion of a periodic review of ratings of Bioscrip, Inc. (Moodys)
18.04.19	BioScrip, Inc. -- Moody's announces completion of a periodic review of ratings of Bioscrip, Inc. (Moodys)
18.04.19	BioScrip, Inc. -- Moody's announces completion of a periodic review of ratings of Bioscrip, Inc. (Moodys)
18.03.19	BioScrip, Inc. -- Moody's places BioScrip's ratings under review for upgrade following the announced merger with HC Group Holdings (Moodys)
18.03.19	HC Group Holdings III, Inc. -- Moody's places HC Group Holding's ratings under review for upgrade following the announced merger with BioScrip (Moodys)
18.03.19	HC Group Holdings III, Inc. -- Moody's places HC Group Holding's ratings under review for upgrade following the announced merger with BioScrip (Moodys)
14.03.19	Ausblick: Bioscrip gewährt Anlegern Blick in die Bücher (finanzen.net)
12.03.19	Ausblick: Bioscrip gewährt Anlegern Blick in die Bücher (finanzen.net)
04.11.18	Ausblick: Bioscrip legt Zahlen zum jüngsten Quartal vor (finanzen.net)
30.07.18	BioScrip, Inc. -- Moody's upgrades BioScrip's CFR to Caa1; outlook stable (Moodys)
30.07.18	BioScrip, Inc. -- Moody's upgrades BioScrip's CFR to Caa1; outlook stable (Moodys)
01.08.17	BioScrip, Inc. -- Moody's rates BioScrip's new debt; Caa2 CFR affirmed (Moodys)
03.03.16	BioScrip, Inc. -- Moody's downgrades BioScrip's CFR to Caa2; outlook stable (Moodys)
13.03.15	BioScrip, Inc. -- Moody's: BioScrip's convertible preferred stock issuance is credit positive; ratings unaffected (Moodys)
05.03.15	BioScrip, Inc. -- Moody's downgrades BioScrip's CFR to Caa1; outlook stable (Moodys)
05.02.14	BioScrip, Inc. -- Moody's rates BioScrip's proposed senior unsecured notes Caa2; B3 CFR affirmed; stable outlook (Moodys)
03.02.14	BioScrip, Inc. -- Moody's: BioScrip's term loan amendment and pending sale of Home Health is credit positive; B3 CFR and stable outlook unaffected (Moodys)
20.12.13	BioScrip, Inc. -- Moody's downgrades BioScrip's CFR to B3 from B2; outlook stable (Moodys)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Novartis	92.75	0.89 %	K V
Nestle	76.36	0.69 %	K V
Swisscom	506.50	0.50 %	K V
Alcon	78.00	0.49 %	K V
Roche Hldg G	252.50	0.44 %	K V
CieFinRichemont	121.90	-0.37 %	K V
Sika	226.60	-0.87 %	K V
ABB	49.02	-1.05 %	K V
Lonza Grp	517.00	-2.64 %	K V
Logitech Intl	70.06	-2.67 %	K V

mehr

04.12.17		Aetna-Kauf durch CVS für 69 Milliarden Dollar ist wohl ausgemachte Sache
27.10.17		CVS wohl an Krankenversicherer Aetna fpr mehr 66 Milliarden Dollar interessiert
14.02.17		Geplatzter Zusammenschluss mit Humana kostet Aetna eine Milliarde Dollar
16.06.15		UnitedHealth will Aetna für Milliarden kaufen
20.08.12		Wall Street Eröffnung: Leicht im Minus, Aetna und Best Buy im Fokus